Latest News about CRSP
Recent news which mentions CRSP
HP To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Monday
December 11, 2023
From Benzinga
From Motley Fool
The 3 Best Cathie Wood Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
From Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
From MarketWatch
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
December 08, 2023
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
December 07, 2023
From Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
December 07, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
Is This News a Setback or a Step Forward for CRISPR Therapeutics?
December 06, 2023
Tickers
CRSP
From Motley Fool
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
December 06, 2023
Tickers
CRSP
From Benzinga
CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases
December 05, 2023
Tickers
CRSP
From Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
From Motley Fool
The Market's Up This Year. Do You Feel Like You Are Winning?
December 04, 2023
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
Where Will Vertex Pharmaceuticals Be in 10 Years?
December 04, 2023
From Motley Fool
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
December 04, 2023
Tickers
CRSP
From Motley Fool
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
December 03, 2023
From Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
From Motley Fool
5 Top Stocks to Buy Before 2024
December 02, 2023
From Motley Fool
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
December 01, 2023
From Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
December 01, 2023
From Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
From InvestorPlace
Cathie Wood's ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception
November 29, 2023
From Benzinga
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
November 29, 2023
From Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
From InvestorPlace
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
November 28, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|